Alpha Partners

Alpha Partners, established in 2014, is a New York-based venture capital firm that specializes in co-investing with early-stage venture capital funds. It focuses on providing growth capital to enable these funds to double down on their leading companies, particularly in the technology sector. Alpha Partners invests between $0.15 million and $2 million, with a preference for companies with revenues between $5 million and $20 million. It seeks to exit investments within four years and does not take board seats or prefer to be a lead investor. Instead, it acts as a co-investor, sharing up to half of the economics on these co-investments.

Zoe van den Bol

Investor

Ben Freeberg

Venture Partner

Steve Gentili

Vice President

Oliver Henry

Investor

Michelle Modest

Investor

Sean O’Brien

CFO

Michael Ryan

Venture Partner

Sam Silvershein

Vice President

8 past transactions

Pearl

Series B in 2024
Pearl Health, established in 2019 and headquartered in West Hollywood, California, specializes in developing artificial intelligence (AI) tools for the dentistry industry. The company offers a suite of products, including Second Opinion, a computer vision platform that identifies dental pathologies; Smart Margin, aiding in dental restoration; Scan Clarity Score, evaluating patient scan quality; and Practice Intelligence, providing office-specific data for decision-making. Pearl's AI technology, cleared by the FDA, recognizes and measures various dental issues, enabling practitioners, labs, and insurers to enhance efficiency, accuracy, and consistency in dental care.

Vi Labs

Funding Round in 2024
Vi Labs is a prominent provider of enterprise AI solutions specifically tailored for the health sector. The company focuses on assisting large health organizations in enhancing member health outcomes while optimizing financial returns. By utilizing a robust technology stack and comprehensive household-level data, Vi Labs employs predictive and personalized engagement strategies. These approaches aim to reduce costs associated with member acquisition and increase the lifetime value of members. Ultimately, Vi Labs' solutions empower health enterprises to improve health outcomes for their members while maximizing overall income.

Thirty Madison

Series C in 2021
Thirty Madison, Inc. is a digital health company based in Astoria, New York, that focuses on providing specialized healthcare solutions for patients with chronic conditions. Founded in 2016, the company operates several condition-specific brands, including Keeps, which offers a subscription-based service for men’s hair loss prevention; Cove, which provides online consultations and prescriptions for migraine treatment; Picnic, targeting allergies; Facet for skin conditions; and NURX for sexual health. Each brand is designed to address the unique needs of its community, offering personalized treatments and support. Thirty Madison emphasizes a human-centered approach, empowering individuals with accessible and effective healthcare solutions tailored to their ongoing conditions.

SpotHero

Series D in 2019
SpotHero Inc. is a leading provider of parking reservation services in North America, enabling drivers to easily locate and secure parking spots through its mobile application and website. Founded in 2011 and headquartered in Chicago, Illinois, with an additional office in Detroit and operations in Toronto, the company allows users to compare prices and reserve discounted parking in garages and lots. The SpotHero application connects various parking facilities, including garages and valet services, facilitating seamless data exchange and payment processing. By streamlining the parking experience, SpotHero aims to make urban areas more accessible and enhance connectivity for drivers.

Intelliboxes

Venture Round in 2015
Intellibox is a patented technology which makes it quick and easy for customers to sell their phone for cash. Customers can take their used mobile phones to an Intellibox, complete the evaluation in 5 mins and walk away with 100s of pounds.

Cloud Technology Partners

Series B in 2014
Cloud Technology Partners, Inc. specializes in providing cloud application and infrastructure solutions tailored for mid-market and enterprise clients in the United States. Established in 2009 and based in Boston, Massachusetts, the company offers a range of services, including application migration, infrastructure modernization, and cloud strategy consulting. Its product suite features tools such as AppVista, which aids in cloud placement decisions, and PaaSLane, designed for code analysis during migration. The company also provides governance software like CloudCop and a framework for managing multi-tenant applications. By leveraging its extensive cloud-focused service portfolio, Cloud Technology Partners assists organizations in reducing IT costs, streamlining operations, and accelerating their cloud transformation efforts. As of 2017, it operates as a subsidiary of Hewlett Packard Enterprise Company, with additional operations in the EMEA region.

LiveIntent

Series C in 2014
LiveIntent is a technology platform that enhances email as a marketing tool, allowing brands to effectively connect with their customers. The company specializes in people-based targeting, email monetization, and identity resolution, providing solutions that benefit both marketers and publishers. By facilitating direct engagement with audiences, LiveIntent helps businesses drive sales and increase revenue while ensuring user privacy is respected. The platform aims to bridge the gaps between brands and their target audiences, maximizing the potential of email marketing.

Metra Biosystems

Venture Round in 1992
Metra Biosystems specializes in the development and commercialization of diagnostic products aimed at detecting and managing metabolic bone and joint diseases. The company's focus is on creating innovative diagnostic devices that address disorders related to bone and cartilage. By providing accurate and reliable tools for healthcare professionals, Metra Biosystems contributes to improved patient care and outcomes in the field of metabolic bone health.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.